Skip to content

Effect of Sub-Anesthetic Dose of Esketamine on Postoperative Sleep Disturbance in Elderly Patients Undergoing Total Knee Arthroplasty

Effect of Sub-Anesthetic Dose of Esketamine on Postoperative Sleep Disturbance in Elderly Patients Undergoing Total Knee Arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125116
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Esketamine group:Intravenous infusion of esketamine
Normal saline group:Intravenous infusion of normal saline

Sponsors

The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 60 to 74 years. Both sexes are included. 2.Patients undergoing elective unilateral total knee arthroplasty under general anesthesia. 3.American Society of Anesthesiologists (ASA) physical status classification I-II. 4.18.5kg/m² = BMI < 32.5kg/m².

Exclusion criteria

Exclusion criteria: 1.Patients who decline to participate. 2.Allergic to anesthetics. 3.History or family history of malignant hyperthermia. 4.History of local anesthetic allergy, local skin infection, bleeding at puncture site, etc. 5.Severe coagulation dysfunction. 6.Severe cardiac, pulmonary, hepatic, or renal dysfunction. 7.Severe mental disorders. 8.History of drug addiction or abuse.

Design outcomes

Primary

MeasureTime frame
Incidence of sleep disturbance;postoperative resting pain level;

Secondary

MeasureTime frame
Intraoperative remifentanil consumption;incidence of adverse effects;Frequency of PCIA delivery;Time to extubation;

Countries

China

Contacts

Public ContactRuifeng Zeng

The 2nd Affiliated Hospital of Wenzhou Medical University

ruifengzeng@163.com+86 138 5773 4776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026